Log in or Sign up for Free to view tailored content for your specialty!
Geriatrics News
Intranasal esketamine shows promise for treatment-resistant depression
NEW YORK — Results from two phase-3 studies of esketamine presented here demonstrated clinical significance in treatment-resistant depression.
Mild TBI increases dementia risk
Veterans who had a mild traumatic brain injury and did not lose consciousness were at increased risk for dementia, according to findings recently published in JAMA Neurology.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Rethinking the purpose of benzodiazepines
NEW ORLEANS — Benzodiazepines in older patients with delirium may be an acceptable pharmacological approach after all, according to Alan Dow, MD, MSHA, a general internist at Virginia Commonwealth University and member of the ACP Internal Medicine Meeting planning committee.
Off-label antipsychotic use rising among community-dwelling dementia patients
Although off-label antipsychotic drug use has declined in nursing homes due to efforts from the CMS, use of these drugs has increased slightly among patients with dementia living in the community, according to a report issued by the AARP Public Policy Institute.
Higher education linked with lower risk for dementia in African-Americans
Study findings demonstrated that higher education level was significantly associated with lower risk for dementia later in life among African-Americans.
Antipsychotics, benzodiazepines should not be used to treat delirium
ORLANDO, Fla. – Despite their frequent off-label use in hospitals, antipsychotics and benzodiazepines do not treat delirium in older patients, even in palliative care, according to a presenter at Hospital Medicine 2018.
Opioid initiation cuts antipsychotic use in persons with Alzheimer’s disease
Initiation of prescription opioid analgesics slightly reduced the use of both antipsychotic medications and benzodiazepines in community-dwelling adults with Alzheimer’s disease living in Finland, according to findings published in International Psychogeriatrics.
Simple tool predicts dementia better than previous tests
The Montreal Parkinson Risk of Dementia Scale displayed a predictive validity that was identical or greater than previously described algorithms that utilized biomarker assessments, according to findings recently published in JAMA Neurology.
Prevalence, mortality, cost of Alzheimer’s disease continues to skyrocket
The 2018 Alzheimer’s Disease Facts and Figures report issued by the Alzheimer’s Association revealed that the cost of care for Alzheimer’s disease or other dementias is expected to exceed a quarter of a trillion dollars for the second year in a row, and the number of related deaths rose by 123%, according to a press release issued by the organization.
Excessive daytime sleepiness may raise risk for dementia
Excessive daytime sleepiness was linked to an increase in longitudinal beta amyloid accumulation among elderly adults without dementia, indicating excessive daytime sleepiness may be a risk factor for dementia, according to study findings.
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read